LUND, SE / ACCESS Newswire / June 3, 2025 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - Spago Nanomedical AB (publ) announced today that the Data Monitoring Committee (DMC) recommends the ongoing ...

Notice to convene extraordinary GENERAL MEETING REGARDING EXTRAORDINARY DIVIDENDGUBRA A/SCVR NO. 30 51 40 41To the shareholders of Gubra A/S (CVR no. 30 51 40 41), notice is hereby given to convene an ...

Second Patient Treated with HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation LONDON, UNITED KINGDOM / ACCESS Newswire / June 3, 2025 / Hemogenyx Pharmaceuticals plc is pleased to ...

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 ...

LOS ANGELES, CA / ACCESS Newswire / June 2, 2025 / Traditionally, treating varicose veins often required a series of tedious clinic visits, long wait times, and a one-size-fits-all approach. For many, ...

Thermogenic Hydration Formula Backed by Cold-Induced Fat Burning Science Now Gaining Attention for Safe, Sustainable Weight ...

"This award means our facilities have met rigorous, nationally recognized standards for quality and excellence," said Dr.

THE WOODLANDS, TEXAS / ACCESS Newswire / June 2, 2025 / Mann Eye Institute, Texas's premier vision correction and eye care ...

Survey Identifies the Vendors and Capabilities Driving FWA Detection, Overpayment Recovery, and Claims Accuracy Across U.S. Payers NEW YORK CITY, NY / ACCESS Newswire / June 2, 2025 / As healthcare ...

Vantive to Invest More Than $1 Billion in Advancing Kidney Care and Vital Organ Support Through Digitally-Enabled TherapiesFive-year global investment to fuel R&D and manufacturing expansion, ...

Ochre Bio appoints ex- Eli Lilly and AstraZeneca VP as Non-Executive DirectorThe appointment and ongoing science team expansion will help the company advance late-stage liver disease therapeutics29th ...

Itepekimab met the primary endpoint in one of two COPD phase 3 studies AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former ...